Characterizing HPV Vaccine Sentiments and Content on Instagram

by Hauer, M.K, Kearney, M.D, Leader, A.E, Massey, P.M, Selvan, P.
Published 2019

Examining the Influence of Religious and Spiritual Beliefs on HPV Vaccine Uptake Among College Women

by Adamu, A.M, Best, A.L, Cunningham, E., Daley, E., Delva, J., Logan, R., Thomas, M., Thompson, E.L, Vamos, C.
Published 2019

Oropharyngeal cancer is no longer a disease of younger patients and the prognostic advantage of Human Papillomavirus is attenuated among older patients: Analysis of the National Ca...

by D'Souza, G., Eisele, D.W, El Asmar, M., Fakhry, C., Faraji, F., Fung, N., Rettig, E.M, Zaidi, M.
Published 2018

Racial/ethnic variation in the prevalence of vaccine-related human papillomavirus genotypes

by Adler-Storthz, K., Bracamontes, C.G, Dillon, L.M, Follen, M., Guillaud, M., Montealegre, J.R, Scheurer, M.E, Sikora, A.G, Varier, I.
Published 2019

Physical assessment in pharmacy practice: Perspectives from pharmacists, nonpharmacist health care providers and the public

by Leong, C., Soufi, L.
Published 2021

Vaccine knowledge, awareness and hesitancy: A cross sectional survey among parents residing at sandakan district, sabah

by Al-Worafi, Y.M, Hanafiah, N.H.M, Ibrahim, B., Lean, Q.Y, Ming, L.C, Voo, J.Y.H
Published 2021

The Human Virome: Viral Metagenomics, Relations with Human Diseases, and Therapeutic Applications

by Bai, G.-H, Chen, S.-Y, Hsu, Y.-H, Lin, S.-C
Published 2022

Effectiveness of catch-up human papillomavirus vaccination on incident cervical neoplasia in a US health-care setting: a population-based case-control study

by Gregorich, S.E, Huchko, M.J, Kulasingam, S., Kuppermann, M., Lam, J.O, Leyden, W.A, Sawaya, G.F, Silverberg, M.J, Smith-McCune, K.K
Published 2018

Frequent HPV-independent p16/INK4A overexpression in head and neck cancer

by Chakravarthy, A.R, Chester, K., Feber, A., Fenton, T.R, Forde, C.T, Forster, M., Hayes, D.N, Jay, A., Jones, T.M, Kalavrezos, N., Lechner, M., Masterson, L., McIndoe, R.A, O'Flynn, P., Vaz, F.M, Walter, V., Weinberger, P.M
Published 2018

The important role of cisplatin in the treatment of HPV-positive oropharyngeal cancer assessed by real-world data analysis

by Berkhof, J., Brakenhoff, R.H, Hoebers, F.J.P, Klausch, T., Licitra, L., Nauta, I.H, Poli, T., René Leemans, C., Scheckenbach, K., van de Ven, P.M
Published 2021

Double positivity for HPV-DNA/p16ink4a is the biomarker with strongest diagnostic accuracy and prognostic value for human papillomavirus related oropharyngeal cancer patients

by Aguila, A., Alejo, M., Alemany, L., Bagué, S., Blazquez, C., Bonfill, T., Bosch, F.X, Bravo, I.G, Clavero, O., de Sanjosé, S., Gomà, M., Guix, M., Hijano, R., Holzinger, D., Leon, X., Lloveras, B., Marquez, S., Mena, M., Mesia, R., Nogués, J., Pavon, M.A, Pawlita, M., Quer, M., Quiros, B., Taberna, M., Torres, M., Tous, S.
Published 2018

Physician practice variation in head and neck cancer therapy: Results of a national survey

by Agnès, D.-B, Antoine, N., Emilien, C., Fanny, C., Pascale, G., Pierre, B., Sébastien, L., Sébastien, V.
Published 2021

Primary surgery for human papillomavirus-associated oropharyngeal cancer: Survival outcomes with or without adjuvant treatment

by Cramer, J.D, Duvvuri, U., Ferris, R.L, Kim, S.
Published 2018

Comparative genomic analysis of oral versus laryngeal and pharyngeal cancer

by van den Brekel, M.W.M, Vens, C., Verhagen, C.V.M, Verheij, M., Vossen, D.M, Wessels, L.F.A
Published 2018

Association between the TAP1 gene polymorphisms and recurrent respiratory papillomatosis in patients from Western Mexico: A pilot study

by Araujo-Caballero, V., Cazarez-Navarro, G., Govea-Camacho, L.H, Hernandez-Cañaveral, I.I, Martinez-Lopez, E., Muñoz-Valle, J.F, Ortiz-Hernandez, E., Palomares-Marin, J., Rodriguez-Preciado, S.Y
Published 2021

Staging HPV-related oropharyngeal cancer: Validation of AJCC-8 in a surgical cohort

by Albergotti, W., Andersen, P., Bertolet, M., Clayburgh, D., Duvvuri, U., Ferris, R.L, Geltzeiler, M., Gleysteen, J., Gross, N., Kim, S., Li, R., Olson, B., Persky, M.
Published 2018

A phase I trial adding poly(ADP-ribose) polymerase inhibitor veliparib to induction carboplatin-paclitaxel in patients with head and neck squamous cell carcinoma: Alliance A091101

by de Souza, J.A, Foster, N.R, Jelinek, M.J, Munster, P.N, Schwartz, G.K, Seiwert, T.Y, Vokes, E.E, Zoroufy, A.J
Published 2021

Head and neck cancer organoids established by modification of the CTOS method can be used to predict in vivo drug sensitivity

by Lindemann, A., Myers, J.N, Osman, A.A, Patel, A.A, Takahashi, H., Takahashi, Y., Tanaka, N., Zhao, M.
Published 2018

Nivolumab vs investigator's choice in recurrent or metastatic squamous cell carcinoma of the head and neck: 2-year long-term survival update of CheckMate 141 with analyses by tumor...

by Blumenschein, G., Jr, Colevas, A.D, Docampo, L.C.I, Even, C., Fayette, J., Ferris, R.L, Gillison, M.L, Guigay, J., Haddad, R., Harrington, K.J, Jayaprakash, V., Kasper, S., Kiyota, N., Li, L., Licitra, L., Lynch, M., Rordorf, T., Saba, N.F, Tahara, M., Vokes, E.E, Worden, F.
Published 2018